The Wilms' tumor gene Wt1 is required for normal development of the retina

EMBO Journal

Volumn 21, Issue 6, 2002, Pages 1398-1405

  Wagner, Kay Dietrich ^a   Wagner, Nicole ^a   Vidal, Valerie P I ^a   Schley, Gunnar ^b   Wilhelm, Dagmar ^c   Schedl, Andreas ^d   Englert, Christoph ^e   Scholz, Holger ^e  

^a DIVISION OF REPRODUCTIVE BIOLOGY   (United States)

^b UNIVERSITY OF LONDON   (United Kingdom)

^c RESEARCH AND DEVELOPMENT   (Australia)

^d College of Chemistry and Molecular Engineering ^*  (China)

^e HUMBOLDT UNIVERSITY   (Germany)

Author keywords

Apoptosis; POU domain factors; Retina development; Retinal ganglion cells; Wilms' tumor gene

Indexed keywords

GENE PRODUCT; PROTEIN WT1; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; APOPTOSIS; ARTICLE; ARTIFICIAL CHROMOSOME; CELL SURVIVAL; CONTROLLED STUDY; EMBRYO; FEMALE; GENE CONSTRUCT; GENE DISRUPTION; GENE SEQUENCE; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; ONCOGENE; OPTIC NERVE FIBER; PRIORITY JOURNAL; PROTEIN EXPRESSION; RETINA DEVELOPMENT; RETINA GANGLION CELL; SEQUENCE ANALYSIS;

ANIMALS; CELL DIVISION; CHROMOSOMES, ARTIFICIAL, YEAST; FEMALE; GENE EXPRESSION; GENES, WILMS TUMOR; GENETIC COMPLEMENTATION TEST; HOMEODOMAIN PROTEINS; HUMANS; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MICE, TRANSGENIC; OPTIC NERVE; RETINA; RETINAL GANGLION CELLS; RNA, MESSENGER; STEM CELLS; TRANS-ACTIVATION (GENETICS); TRANSCRIPTION FACTORS; TUMOR CELLS, CULTURED; WILMS TUMOR; WT1 PROTEINS;

ANIMALIA; VERTEBRATA;

EID: 0037086642     PISSN: 02614189     EISSN: None     Source Type: Journal    
DOI: 10.1093/emboj/21.6.1398     Document Type: Article

References (49)

1. Tumors in the kidney, renal pelvis and ureter
2. Aniridia, Wilms' tumor and human chromosome 11
3. A simplified in situ hybridization protocol using non-radioactively labeled probes to detect abundant and rare mRNAs on tissue sections
4. Isolation, characterization and expression of the murine Wilms' tumor gene (WT1) during kidney development
5. Cell fate determination in the vertebrate retina
6. WT1 interacts with the splicing factor U2AF65 in an isoform-dependent manner and can be incorporated into spliceosomes
7. WT1 suppresses synthesis of the epidermal growth factor receptor and induces apoptosis
8. Truncated WT1 mutants alter the subnuclear localization of the wild-type protein
9. Induction of p21 by the Wilms' tumor suppressor gene WT1
10. Role of transcription factors Brn-3.1 and Brn-3.2 in auditory and visual system development
11. POU domain factor Brn-3b is essential for retinal ganglion cell differentiation and survival but not for initial cell fate specification
12. POU domain factor Brn-3b is required for the development of a large set of retinal ganglion cells
13. Recombinant genomes which express chloramphenicol acetyltransferase in mammalian cells
14. Alternative splicing and genomic structure of the Wilms tumor gene WT1
15. Two splice variants of the Wilms' tumor 1 gene have distinct functions during sex determination and nephron formation
16. The genetics of Wilms' tumor - A case of disrupted development
17. The Wilms tumor suppressor gene Wt1 is required for development of the spleen
18. Molecular regulators involved in vertebrate eye development
19. WT-1 is required for early kidney development
20. + ribonucleoprotein
21. Subnuclear localization of WT1 in splicing or transcription factor domains is regulated by alternative splicing
22. Wilms tumor and the WT1 gene
23. The Wilms' tumor suppressor WT1 encodes a transcriptional activator of amphiregulin
24. The Ath5 proneural genes function upstream of Brn3 POU domain transcription factor genes to promote retinal ganglion cell development
25. Genetics of Wilms' tumor
26. The Wilms' tumor gene product (WT1) modulates the response to 1, 25-dihydroxyvitamin D3 by induction of the vitamin D receptor (VDR)
27. The Wilms' tumor suppressor WT1: Approaches to gene function
28. YAC analysis reveals Wilms' tumour 1 gene activity in the proliferating coelomic epithelium, developing diaphragm and limb
29. YAC complementation shows a requirement for Wt1 in the development of epicardium, adrenal gland and throughout nephrogenesis
30. Nuclear localization of the protein encoded by the Wilms' tumor gene WT1 in embryonic and adult tissues
31. Aniridia. A review
32. Wt1 regulates the expression of the major glomerular podocyte membrane protein Podocalyxin
33. Expression of the Wilms' tumor gene Wt1 in the murine urogenital system
34. The candidate Wilms' tumour gene is involved in genitourinary development
35. Expression of the Wilms' tumor suppressor gene Wt1 during mouse embryogenesis
36. The WT1 Wilms tumor gene product: A developmentally regulated transcription factor in the kidney that functions as a tumor suppressor
37. Influence of PAX6 gene dosage on development: Overexpression causes severe eye abnormalities
38. A far upstream cis-element is required for Wilms' tumor-1 (WT1) gene expression in renal cell culture
39. The development of the vertebrate retina: A comparative survey
40. Positional cloning and characterization of a paired box- and homeobox-containing gene from the aniridia region
41. Activation of vitamin D receptor by the Wilms' tumor gene product mediates apoptosis of renal cells
42. Abnormal polarization and axon outgrowth in retinal ganglion cells lacking the POU-domain transcription factor Brn-3b
43. Requirement for Brn-3b in early differentiation of postmitotic retinal ganglion cell precursors
44. Brn-3b: A POU domain gene expressed in a subset of retinal ganglion cells
45. The Brn-3 family of POU-domain factors: Primary structure, binding specificity and expression in subsets of retinal ganglion cells and somatosensory neurons
46. Role of the Brn-3 family of POU-domain genes in the development of the auditory/vestibular, somatosensory and visual systems
47. Growth inhibition of human leukemic cells by WT1 (Wilms' tumor gene) antisense oligonucleotides: Implications for the involvement of WT1 in leukemogenesis
48. 2/M arrest in leukemic cells